Clinical Trial Update: Apomorphine Effects on Pain in Parkinson's Disease [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update regarding apomorphine’s effects on pain in Parkinson’s disease across Phase 2 and Phase 3 is listed, with the status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Apomorphine (apomorphine)

Snippet

Sponsor: University of Calgary | Conditions: Parkinson Disease | Phase 2, Phase 3 | Status: UNKNOWN